Dr. Carter's goal is to try to help patients navigate the complexities of treatment for brain tumor and brain vascular lesions. By focusing on a multidisciplinary strategy with outstanding colleagues at University of California, San Diego, our goal is to tailor treatment correctly for each patient and support them as the seek both medical and surgical care for their condition.
Bob S. Carter is now Professor and Chief of Neurosurgery at the University of California, San Diego, where he specializes in the treatment of primary brain tumors and complex intracranial surgery for skull base and vascular lesions. Dr. Carter trained at the Massachusetts General Hospital. Dr. Carter obtained his M.D. and Ph.D. degrees at the Johns Hopkins Medical School, earning Alpha Omega Alpha, Phi Beta Kappa, and Delta Omega distinction. Dr. Carter's work at UCSD is focused on complex brain and spinal cord surgery. Dr. Carter is active in national and international neurosurgery organizations including serving as an Associate Editor of Neurosurgery, editorial board member of the Asian Journal of Neurosurgery as well as program committee member of the International Stroke Conference of the American Stroke Association. He has served on the Executive Boards of the New England Neurosurgical Society and the Joint Section on Cerebrovascular Disease. In the laboratory, Dr. Carter's work has been cited over 15,000 times in the literature; he performed a post-doctoral research fellowship in gene therapy at the Whitehead Institute, Cambridge, MA and Children's Hospital, Boston with Dr. Richard Mulligan. Dr. Carter has a long history of NIH funding for his work on chimeric T-cell receptor therapy for glioma. In 2008, he and colleagues described the first use of exosomes as an RNA based serum biomarker for glioma in a report in Nature Cell Biology; this remains an active area of ongoing research.